国际口腔医学杂志 ›› 2018, Vol. 45 ›› Issue (4): 408-413.doi: 10.7518/gjkq.2018.04.007

• 综述 • 上一篇    下一篇

纳米银在口腔感染性疾病防治中的研究进展

刘丹, 任彪, 程磊   

  1. 口腔疾病研究国家重点实验室 国家口腔疾病临床医学研究中心;四川大学华西口腔医院牙体牙髓病科 成都 610041
  • 收稿日期:2017-11-27 修回日期:2018-03-30 出版日期:2018-07-02 发布日期:2018-07-02
  • 通讯作者: 程磊,教授,博士,Email:chengleidentist@163.com
  • 作者简介:刘丹,硕士,Email:1427289174@qq.com
  • 基金资助:
    四川省国际科技合作与交流研发项目(2017HH0008)

Research development of silver nanoparticle on prevention and treatment of oral infectious disease

Liu Dan, Ren Biao, Cheng Lei.   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Conservative Dentistry and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2017-11-27 Revised:2018-03-30 Online:2018-07-02 Published:2018-07-02
  • Supported by:
    This study was supported by Research and Development Project of International Science and Technology Cooperation and Exchange in Sichuan Province (2017HH0008).

摘要: 纳米银是以纳米技术为基础研制而成的一种新型抗菌产品,因其具有传统无机抗菌剂无法比拟的抗菌效果,安全性高、效力持久,是一种长效性的抗菌剂,故被广泛用于各个领域。在口腔医学领域,纳米银亦被广泛研究与应用,本文就纳米银的抗菌机制与特性及其在口腔感染性疾病防治中的相关研究进行综述。

关键词: 纳米银, 抗菌机制, 口腔感染性疾病

Abstract: Silver nanoparticle is a novel antibacterial agent produced by nanotechnology research. This nanoparticle is widely used in various fields for its remarkable antibacterial effect compared with those of traditional inorganic antibacterial agents. Silver nanoparticle also presents considerable safety, lasting efficacy and a long-term antimicrobial effect. In this review, we mainly describe the antibacterial mechanism and characteristics of silver nanoparticles and related research on the prevention of infectious microbial diseases and treatment of oral cavity.

Key words: silver nanoparticle, antibacterial mechanism, oral microorganisms’, infectious disease;

中图分类号: 

  • R781
[1] Franci G, Falanga A, Galdiero S, et al.Silver nano-particles as potential antibacterial agents[J]. Mole-cules, 2015, 20(5): 8856-8874.
[2] Pal S, Tak YK, Soing JM.Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli[J]. Appl Environ Micro-biol, 2007, 73(6): 1712-1720.
[3] Cardozo VF, Oliveira AG, Nishio EK, et al.Antibac-terial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains[J]. Ann Clin Microbiol Antimicrob, 2013. doi:10.1186/1476-0711-12-12.
[4] Smekalova M, Aragon V, Panacek A, et al.Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens[J]. Vet J, 2016, 209: 174-179.
[5] Jena P, Mohanty S, Mallick R, et al.Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells[J]. Int J Nanomedicine, 2012, 7(9): 1805-1818.
[6] Durán N, Durán M, de Jesus MB, et al. Silver nano-particles: a new view on mechanistic aspects on an-timicrobial activity[J]. Nanomedicine, 2016, 12(3): 789-799.
[7] Perugini Biasi-Garbin R, Saori Otaguiri E, Morey AT, et al. Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biolo-gically produced silver nanoparticles[J]. Evid Based Complement Alternat Med, 2015, 2015: 861497.
[8] Melo MA, Guedes SF, Xu HH, et al.Nanotechnology-based restorative materials for dental caries mana-gement[J]. Trends Biotechnol, 2013, 31(8): 459-467.
[9] Corrêa JM, Mori M, Sanches HL, et al.Silver nano-particles in dental biomaterials[J]. Int J Biomater, 2015, 2015: 485275.
[10] Imazato S.Antibacterial properties of resin com-posites and dentin bonding systems[J]. Dent Mater, 2003, 19(6): 449-457.
[11] Cheng L, Weir MD, Xu HH, et al.Antibacterial amorphous calcium phosphate nanocomposites with a quaternary ammonium dimethacrylate and silver nanoparticles[J]. Dent Mater, 2012, 28(5): 561-572.
[12] Cheng L, Zhang K, Weir MD, et al.Effects of anti-bacterial primers with quaternary ammonium and nano-silver on Streptococcus mutans impregnated in human dentin blocks[J]. Dent Mater, 2013, 29(4): 462-472.
[13] Cheng L, Weir MD, Zhang K, et al.Dental primer and adhesive containing a new antibacterial quater-nary ammonium monomer dimethylaminododecyl methacrylate[J]. J Dent, 2013, 41(4): 345-355.
[14] Shantiaee Y, Dianat S, Khani H, et al.Cytotoxicity comparison of nanosilver coated gutta-percha with guttaflow and normal gutta-percha on L929 fibro-blast with MTT assay[J]. J Dent School, 2011, 29(2): 62-68.
[15] Lotfi M, Vosoughhosseini S, Ranjkesh B, et al.An-timicrobial efficacy of nanosilver, sodium hypo-chlorite and chlorhexidine gluconate against Entero-coccus faecalis[J]. Afr J Biotechnol, 2011, 10(35): 6679-6803.
[16] Abbasipour F, Akheshteh V, Rastqar A, et al.Com-paring the effects of mineral trioxide aggregate and calcium enriched mixture on neuronal cells using an electrophysiological approach[J]. Iran Endod J, 2012, 7(2): 79-87.
[17] Samiei M, Aghazadeh M, Lotfi M, et al.Antimicro-bial efficacy of mineral trioxide aggregate with and without silver nanoparticles[J]. Iran Endod J, 2013, 8(4): 166-170.
[18] Jonaidi-Jafari N, Izadi M, Javidi P.The effects of silver nanoparticles on antimicrobial activity of pro-root mineral trioxide aggregate (MTA) and calcium enriched mixture (CEM)[J]. J Clin Exp Dent, 2016, 8(1): e22-e26.
[19] Salerno C, Pascale M, Contaldo M, et al.Candida-associated denture stomatitis[J]. Med Oral Patol Oral Cir Bucal, 2011, 16(2): e139-e143.
[20] Gendreau L, Loewy ZG.Epidemiology and etiology of denture stomatitis[J]. J Prosthodont, 2011, 20(4): 251-260.
[21] Navabi N, Gholamhoseinian A, Baghaei B, et al.Risk factors associated with denture stomatitis in healthy subjects attending a dental school in Sou-theast Iran[J]. Sultan Qaboos Univ Med J, 2013, 13(4): 574-580.
[22] Chandra J, Mukherjee PK, Leidich SD, et al.Anti-fungal resistance of candidal biofilms formed on denture acrylic in vitro[J]. J Dent Res, 2001, 80(3): 903-908.
[23] Rowan R, McCann M, Kavanagh K. Analysis of the response of Candida albicans cells to silver (Ⅰ)[J]. Med Mycol, 2010, 48(3): 498-505.
[24] Acosta-Torres LS, Mendieta I, Nuñez-Anita RE, et al.Cytocompatible antifungal acrylic resin contai-ning silver nanoparticles for dentures[J]. Int J Na-nomedicine, 2012, 7: 4777-4786.
[25] Monteiro DR, Gorup LF, Takamiya AS, et al.Silver distribution and release from an antimicrobial den-ture base resin containing silver colloidal nanopar-ticles[J]. J Prosthodont, 2012, 21(1): 7-15.
[26] Darouiche RO.Treatment of infections associated with surgical implants[J]. New Engl J Med, 2004, 350(14): 1422-1429.
[27] Schmalzried TP, Amstutz HC, Au MK, et al.Etio-logy of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infec-tions[J]. Clin Orthop Relat Res, 1992(280): 200-207.
[28] Zheng Y, Li J, Liu X, et al.Antimicrobial and osteo-genic effect of Ag-implanted titanium with a nano-structured surface[J]. Int J Nanomedicine, 2012, 7: 875-884.
[29] Passos SP, Gressler May L, Faria R, et al.Implant-abutment gap versus microbial colonization: clinical significance based on a literature review[J]. J Biomed Mater Res Part B Appl Biomater, 2013, 101(7): 1321-1328.
[30] Antoci V Jr, Adams CS, Parvizi J, et al.The inhi-bition of Staphylococcus epidermidis biofilm forma-tion by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infec-tion[J]. Biomaterials, 2008, 29(35): 4684-4690.
[31] Vester H, Wildemann B, Schmidmaier G, et al.Gentamycin delivered from a PDLLA coating of metallic implants: in vivo and in vitro characteri-sation for local prophylaxis of implantrelated osteo-myelitis[J]. Injury, 2010, 41(10): 1053-1059.
[32] Zhao L, Wang H, Huo K, et al.Antibacterial nano-structured titania coating incorporated with silver nanoparticles[J]. Biomaterials, 2011, 32(24): 5706-5716.
[33] Flores CY, Diaz C, Rubert A, et al.Spontaneous adsorption of silver nanoparticles on Ti/TiO2 surfaces. Antibacterial effect on Pseudomonas aeruginosa[J]. J Colloid Interface Sci, 2010, 350(2): 402-408.
[34] Matsubara VH, Igai F, Tamaki R, et al.Use of silver nanoparticles reduces internal contamination of ex-ternal hexagon implants by Candida albicans[J]. Braz Dent J, 2015, 26(5): 458-462.
[35] Tufekci E, Dixon JS, Gunsolley JC, et al.Prevalence of white spot lesions during orthodontic treatment with fixed appliances[J]. Angle Orthod, 2011, 81(2): 206-210.
[36] Sonesson M, Bergstrand F, Gizani S, et al.Manage-ment of post-orthodontic white spot lesions: an up-dated systematic review[J]. Eur J Orthod, 2017, 39(2): 116-121.
[37] Guzmán-Armstrong S, Chalmers J, Warren JJ, et al.White spot lesions: prevention and treatment[J]. Am J Orthod Dentofacial Orthop, 2010, 138(6): 690-696.
[38] Wang X, Wang B, Wang Y.Antibacterial orthodon-tic cement to combat biofilm and white spot lesions[J]. Am J Orthod Dentofacial Orthop, 2015, 148(6): 974-981.
[39] Metin-Gürsoy G, Taner L, Akca G.Nanosilver coa-ted orthodontic brackets: in vivo antibacterial proper-ties and ion release[J]. Eur J Orthod, 2017, 39(1): 9-16.
[40] Abadi MF, Mehrabian S, Asghari B, et al. Silver nanoparticles as active ingredient used for alcohol-free mouthwash[J]. GMS Hyg Infect Control, 2013, 8(1): Doc05.
[41] Yang JY, Huang CY, Chuang SS, et al.A clinical experience of treating exfoliative wounds using na-nocrystalline silver-containing dressings (Acti-coat)[J]. Burns, 2007, 33(6): 793-797.
[1] 杨晓喻 杨涛 刘长虹 黄丞蔚 李世轶. 抗菌肽P9-0对口腔感染细菌作用机制的初步探讨[J]. 国际口腔医学杂志, 2015, 42(3): 276-280.
[2] 程远 殷艳丽 赵蕾. 龈沟产线菌的研究进展[J]. 国际口腔医学杂志, 2014, 41(5): 593-597.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张京剧. 青年期至中年期颅面复合体变化的头影测量研究[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 刘玲. 镍铬合金中铍对可铸造性和陶瓷金属结合力的影响[J]. 国际口腔医学杂志, 1999, 26(06): .
[3] 王昆润. 在种植体上制作固定义齿以后下颌骨密度的动态变化[J]. 国际口腔医学杂志, 1999, 26(06): .
[4] 王昆润. 重型颌面部炎症死亡和康复病例的实验室检查指标比较[J]. 国际口腔医学杂志, 1999, 26(06): .
[5] 逄键梁. 两例外胚层发育不良儿童骨内植入种植体后牙槽骨生长情况[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 温秀杰. 氟化物对牙本质脱矿抑制作用的体外实验研究[J]. 国际口腔医学杂志, 1999, 26(05): .
[7] 杨春惠. 耳颞神经在颞颌关节周围的分布[J]. 国际口腔医学杂志, 1999, 26(04): .
[8] 王昆润. 牙周炎加重期应选用何种抗生素[J]. 国际口腔医学杂志, 1999, 26(04): .
[9] 杨儒壮 孙宏晨 欧阳喈. 纳米级高分子支架材料在组织工程中的研究进展[J]. 国际口腔医学杂志, 2004, 31(02): 126 -128 .
[10] 严超然,李龙江. 肿瘤靶向药物载体系统的研究进展[J]. 国际口腔医学杂志, 2008, 35(S1): .